title: An insulin-like growth factor II-producing histiocytoma associated with hypoglycemia: analysis of the peptide, its gene expression, and glucose transporter isoforms.
abstract: An insulin-like growth factor II (IGF-II)-producing histiocytoma was detected in a patient presenting with the classical findings of tumor-related hypoglycemia (low serum insulin and IGF-I concentrations, glucose intolerance, and only modestly increased serum IGF-II levels). Acid-gel filtration of serum extracts showed a single peak of IGF-II immunoreactivity that emerged at the same site as the 125I-labeled human IGF-II standard. High-performance liquid chromatography (HPLC) analysis of the tumor IGF-II demonstrated that it had an identical retention time to that of recombinant human IGF-II. The tumor IGF-II content was extremely high, messenger RNA (mRNA) for IGF-II showed a 100-fold increase in expression compared with normal human liver tissue. Of special interest, a newly identified exon (hE1) was shown to be predominantly expressed in the tumor by Northern blot analysis using leader exon-specific rat IGF-II complementary DNA (cDNA) probes. Although the significance of this finding remains uncertain, this is the first evidence of a new transcription unit in the human IGF-II gene. In addition, immunoblotting showed that the levels of the glucose transporters, GLUT1 and GLUT4, in the tumor were low and undetectable, respectively. This finding makes it unlikely that increased glucose consumption by the tumor accounted for the hypoglycemia in this patient. This case report provides an interesting insight into the pathophysiology of tumor-induced hypoglycemia and new evidence of the abnormal regulation of IGF-II gene expression in human tumors.
authors.affiliation: Diabetes Center, Tokyo Women's Medical College, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Wasada
authors.forename: N
authors.initials: N
authors.lastname: Hizuka
authors.forename: M
authors.initials: M
authors.lastname: Yamamoto
authors.forename: K
authors.initials: K
authors.lastname: Haruki
authors.forename: K
authors.initials: K
authors.lastname: Ikejiri
authors.forename: Y
authors.initials: Y
authors.lastname: Oka
authors.forename: T
authors.initials: T
authors.lastname: Asano
authors.forename: M
authors.initials: M
authors.lastname: Aiba
authors.forename: Y
authors.initials: Y
authors.lastname: Hirata
mesh_terms: D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D004910:Erythrocyte Membrane / Q000378:metabolism; D005260:Female; D018219:Histiocytoma, Benign Fibrous / Q000175:diagnosis* / Q000378:metabolism / Q000601:surgery; D006801:Humans; D007003:Hypoglycemia / Q000209:etiology*; D007335:Insulin-Like Growth Factor II / Q000235:genetics / Q000378:metabolism*; D008875:Middle Aged; D009004:Monosaccharide Transport Proteins / Q000378:metabolism*; D009364:Neoplasm Recurrence, Local; D012333:RNA, Messenger / Q000235:genetics / Q000302:isolation & purification / Q000378:metabolism; D051381:Rats; D012186:Retroperitoneal Neoplasms / Q000175:diagnosis* / Q000378:metabolism / Q000601:surgery; D014158:Transcription, Genetic
chemical_list: D001786:Blood Glucose; D009004:Monosaccharide Transport Proteins; D012333:RNA, Messenger; D007335:Insulin-Like Growth Factor II